| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anna-Maria Smolyakova, Ayat Zagzoog, Asher L Brandt, Tallan Black, Kawthar Mohamed, Robert B Laprairi. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895186. |
this surge has been stimulated by an ongoing shift in societal opinions about cannabinoid-based medicines and evidence that cannabidiol, a nonintoxicating plant cannabinoid, has demonstrable anticonvulsant activity in children with treatment-refractory epilepsy. |
2020-03-18 |
2023-08-13 |
Not clear |
| Alexandra Carte. A North American History of Cannabis Use in the Treatment of Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895188. |
a north american history of cannabis use in the treatment of epilepsy. |
2020-03-18 |
2023-08-13 |
human |
| Alexandra Carte. A North American History of Cannabis Use in the Treatment of Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895188. |
there are multiple accounts detailing the specific ailments cannabis has been used to treat, many of which have included epilepsy. |
2020-03-18 |
2023-08-13 |
human |
| Alexandra Carte. A North American History of Cannabis Use in the Treatment of Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895188. |
legalization of marijuana in canada has potentially allowed for further trials, but it is by no means an end to the controversy surrounding the treatment of epilepsy with cannabinoids. |
2020-03-18 |
2023-08-13 |
human |
| Sandra Wahby, Vikram Karnik, Anita Brobbey, Samuel Wiebe, Tolulope Sajobi, Colin Bruce Josephso. Cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy. Journal of neurology, neurosurgery, and psychiatry. vol 90. issue 8. 2020-03-17. PMID:30826738. |
cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy. |
2020-03-17 |
2023-08-13 |
Not clear |
| Sandra Wahby, Vikram Karnik, Anita Brobbey, Samuel Wiebe, Tolulope Sajobi, Colin Bruce Josephso. Cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy. Journal of neurology, neurosurgery, and psychiatry. vol 90. issue 8. 2020-03-17. PMID:30826738. |
to examine whether cannabis use is associated with or mediates psychosocial health in people with epilepsy. |
2020-03-17 |
2023-08-13 |
Not clear |
| Tristan T Sands, Shahryar Rahdari, Michael S Oldham, Eduardo Caminha Nunes, Nicole Tilton, Maria Roberta Cili. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US. CNS drugs. vol 33. issue 1. 2020-03-10. PMID:30460546. |
long-term safety, tolerability, and efficacy of cannabidiol in children with refractory epilepsy: results from an expanded access program in the us. |
2020-03-10 |
2023-08-13 |
Not clear |
| Khalid A Jadoon, Garry D Tan, Saoirse E O'Sulliva. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI insight. vol 2. issue 12. 2020-03-09. PMID:28614793. |
cannabidiol (cbd) is a nonpsychoactive phytocannabinoid used in multiple sclerosis and intractable epilepsies. |
2020-03-09 |
2023-08-13 |
human |
| Valentina Franco, Emilio Perucc. Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. Drugs. vol 79. issue 13. 2020-01-29. PMID:31372958. |
pharmacological and therapeutic properties of cannabidiol for epilepsy. |
2020-01-29 |
2023-08-13 |
Not clear |
| Santoshi Billakota, Orrin Devinsky, Eric Mars. Cannabinoid therapy in epilepsy. Current opinion in neurology. vol 32. issue 2. 2020-01-10. PMID:30676535. |
to review the history, pharmacology, and clinical science of cannabidiol (cbd) in the treatment of epilepsy. |
2020-01-10 |
2023-08-13 |
Not clear |
| Elisabeth Mahas. NICE recommends cannabis based drugs for epilepsy and multiple sclerosis. BMJ (Clinical research ed.). vol 367. 2020-01-08. PMID:31712197. |
nice recommends cannabis based drugs for epilepsy and multiple sclerosis. |
2020-01-08 |
2023-08-13 |
Not clear |
| Jacqui Wis. NHS to fast track access to cannabis based treatment for epilepsy. BMJ (Clinical research ed.). vol 367. 2020-01-08. PMID:31862706. |
nhs to fast track access to cannabis based treatment for epilepsy. |
2020-01-08 |
2023-08-13 |
Not clear |
| Richard D deShazo, Sara B Parker, Daniel Williams, John B Ingram, Mahmoud Elsohly, Kathryn Rodenmeyer, Kyle McCullouc. Marijuana's Effects on Brain Structure and Function: What Do We Know and What Should We Do? A Brief Review and Commentary. The American journal of medicine. vol 132. issue 3. 2019-12-16. PMID:30240677. |
the recent us food and drug administration approval of the marijuana constituent cannabidiol as safe and effective for treatment of 2 rare forms of epilepsy has raised hopes that others of the 500 chemicals in marijuana will be found to be therapeutic. |
2019-12-16 |
2023-08-13 |
Not clear |
| Kathryn M LaFleur, Eric C Neme. What is the role of cannabidiol in refractory epilepsy? JAAPA : official journal of the American Academy of Physician Assistants. vol 32. issue 3. 2019-11-26. PMID:30817475. |
what is the role of cannabidiol in refractory epilepsy? |
2019-11-26 |
2023-08-13 |
Not clear |
| Kathryn M LaFleur, Eric C Neme. What is the role of cannabidiol in refractory epilepsy? JAAPA : official journal of the American Academy of Physician Assistants. vol 32. issue 3. 2019-11-26. PMID:30817475. |
the fda recently approved the first cannabidiol oral medication to treat refractory epilepsy in patients with dravet syndrome and lennox-gastaut syndrome. |
2019-11-26 |
2023-08-13 |
Not clear |
| Kathryn M LaFleur, Eric C Neme. What is the role of cannabidiol in refractory epilepsy? JAAPA : official journal of the American Academy of Physician Assistants. vol 32. issue 3. 2019-11-26. PMID:30817475. |
this article describes the safety and efficacy of cannabidiol treatment in patients with refractory epilepsy. |
2019-11-26 |
2023-08-13 |
Not clear |
| R Mechoula. Cannabis and epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2019-11-20. PMID:28254349. |
cannabis and epilepsy. |
2019-11-20 |
2023-08-13 |
Not clear |
| Anita Slomsk. Fewer Seizures With Cannabidiol in Catastrophic Epilepsy. JAMA. vol 318. issue 4. 2019-11-20. PMID:28742905. |
fewer seizures with cannabidiol in catastrophic epilepsy. |
2019-11-20 |
2023-08-13 |
Not clear |
| Megan Yap, Laura Easterbrook, Jan Connors, Laura Koopman. Use of cannabis in severe childhood epilepsy and child protection considerations. Journal of paediatrics and child health. vol 51. issue 5. 2019-11-20. PMID:29889339. |
use of cannabis in severe childhood epilepsy and child protection considerations. |
2019-11-20 |
2023-08-13 |
human |
| A Suraev, N Lintzeris, J Stuart, R C Kevin, R Blackburn, E Richards, J C Arnold, C Ireland, L Todd, D J Allsop, I S McGrego. Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific reports. vol 8. issue 1. 2019-11-20. PMID:30068968. |
author correction: composition and use of cannabis extracts for childhood epilepsy in the australian community. |
2019-11-20 |
2023-08-13 |
Not clear |